SEC Filing Summary: SIGA Technologies, Inc. (8-K)
Business Context and Reporting Period
This Form 8-K was filed on March 18, 2015, by SIGA Technologies, Inc., a Delaware corporation. The report addresses a critical corporate event regarding the delisting of the Company's securities from The Nasdaq Stock Market.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the regulatory status of the Company's stock listing.
Material Changes
- Delisting Determination: Nasdaq determined that SIGA Technologies' securities will be delisted from the Nasdaq Global Market.
- Trading Suspension: Trading of common shares was suspended at the opening of business on Friday, March 20, 2015.
- Future Trading Venue: The Company expects its shares to be eligible for quotation on the OTC Markets under the symbol "SIGAQ".
- Cause of Delisting: The delisting is a direct consequence of the Company's Chapter 11 bankruptcy filing on September 16, 2014.
- Underlying Cause: The Chapter 11 filing was precipitated by ongoing litigation with PharmAthene, Inc.
Outlook, Risks, and Management Commentary
Management notes that the delisting decision was reached by the Nasdaq Staff under Listing Rules 5101, 5110(b), and IM-5101-1. The primary risk highlighted is the loss of listing on a national securities exchange, resulting in a move to the over-the-counter (OTC) market. No forward-looking financial guidance or specific contingency plans beyond the expected OTC trading symbol are provided in this filing.
Investor Verification Checklist
- Verify the current trading status and symbol ("SIGAQ") on OTC Markets.
- Review the Company's Chapter 11 bankruptcy proceedings and the status of the litigation with PharmAthene, Inc.
- Confirm the impact of the delisting on shareholder rights and liquidity.
- Examine subsequent filings for updates on the bankruptcy reorganization plan.